Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional Triple-negative Placebo-controlled Personalized Prospective Study "Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia"

NCT06176456 is registered in ClinicalTrials.gov with Moscow Psychiatric Hospital No. 1 Named after N.A. Alexeev as lead sponsor.

NCT NCT06176456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06176456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional Triple-negative Placebo-controlled Personalized Prospective Study "Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia"
Lead sponsor
Moscow Psychiatric Hospital No. 1 Named after N.A. Alexeev
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2023
Completion date
November 1, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar affective disorder, catatonia, schizo affective disorder, schizophrenia